2024-07-04 10:45:00
This spring, Arcede Pharma has worked hard to find a financing solution for the continued work on RCD405, but has not succeeded. Consequently the board of directors is now proposing a voluntary liquidation of the company and intends to propose a delisting of the company's shares from Spotlight Stock Market.
Read the full article at biostock.se (https://www.biostock.se/en/):
https://www.biostock.se/en/2024/07/arcede-pharma-heading-towards-liquidation/
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se